Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:22:37.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:38:11.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T16:40:16.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T17:00:47.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with a minimal header and navigation, indicating that access to the record is blocked.
    Difference
    18%
    Check dated 2026-09-21T22:05:20.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, signaling a new version of the page. This update reflects a content or metadata refresh rather than a user-facing feature change.
    Difference
    0.1%
    Check dated 2026-08-31T16:45:10.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.